Random Comparison of Guaiac and Immunochemical Fecal Occult Blood Tests for Colorectal Cancer in a Screening Population

Gastroenterology

Volumn 135, Issue 1, 2008, Pages 82-90

  van Rossum, Leo G ^a   van Rijn, Anne F ^b   Laheij, Robert J ^a   van Oijen, Martijn G ^a   Fockens, Paul ^b   van Krieken, Han H ^a   Verbeek, Andre L ^a   Jansen, Jan B ^a   Dekker, Evelien ^b  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

GUAIAC;

ADULT; AGED; ARTICLE; CANCER SCREENING; CLINICAL TRIAL; COLORECTAL ADENOMA; COLORECTAL CANCER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; DYSPLASIA; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOCHEMISTRY; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; OCCULT BLOOD TEST; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SENSITIVITY AND SPECIFICITY;

EID: 46049103362     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2008.03.040     Document Type: Article

References (46)

1. Stroehlein J.R., Fairbanks V.F., McGill D.B., et al. Hemoccult detection of fecal occult blood quantitated by radioassay. Am J Dig Dis 21 (1976) 841-844
2. Winawer S.J. Fecal occult blood testing. Am J Dig Dis 21 (1976) 885-888
3. Young G.P., St-John D.J., Winawer S.J., et al. Choice of fecal occult blood tests for colorectal cancer screening: recommendations based on performance characteristics in population studies: a WHO (World Health Organization) and OMED (World Organization for Digestive Endoscopy) report. Am J Gastroenterol 97 (2002) 2499-2507
4. Cummings K.M., Michalek A., Mettlin C., et al. Screening for colorectal cancer using the Hemoccult II stool guaiac slide test. Cancer 53 (1984) 2201-2205
5. Hardcastle J.D., Armitage N.C., Chamberlain J., et al. Fecal occult blood screening for colorectal cancer in the general population. Results of a controlled trial. Cancer 58 (1986) 397-403
6. Faivre J., Arveux P., Milan C., et al. Participation in mass screening for colorectal cancer: results of screening and rescreening from the Burgundy study. Eur J Cancer Prev 1 (1991) 49-55
7. Kronborg O., Fenger C., Olsen J., et al. Randomised study of screening for colorectal cancer with faecal-occult-blood test. Lancet 348 (1996) 1467-1471
8. Miller S.F., and Knight A.R. The early detection of colorectal cancer. Cancer 40 (1977) 945-949
9. Mandel J.S., Church T.R., Bond J.H., et al. The effect of fecal occult-blood screening on the incidence of colorectal cancer. N Engl J Med 343 (2000) 1603-1607
10. Hughes K., Leggett B., Del Mar C., et al. Guaiac versus immunochemical tests: faecal occult blood test screening for colorectal cancer in a rural community. Aust N Z J Public Health 29 (2005) 358-364
11. Woo H.Y., Mok R.S., Park Y.N., et al. A prospective study of a new immunochemical fecal occult blood test in Korean patients referred for colonoscopy. Clin Biochem 38 (2005) 395-399
12. Launoy G.D., Bertrand H.J., Berchi C., et al. Evaluation of an immunochemical fecal occult blood test with automated reading in screening for colorectal cancer in a general average-risk population. Int J Cancer 115 (2005) 493-496
13. Vilkin A., Rozen P., Levi Z., et al. Performance characteristics and evaluation of an automated-developed and quantitative, immunochemical, fecal occult blood screening test. Am J Gastroenterol 100 (2005) 2519-2525
14. Levi Z., Rozen P., Hazazi R., et al. A quantitative immunochemical fecal occult blood test for colorectal neoplasia. Ann Intern Med 146 (2007) 244-255
15. Gopalswamy N., Stelling H.P., Markert R.J., et al. A comparative study of eight fecal occult blood tests and HemoQuant in patients in whom colonoscopy is indicated. Arch Fam Med 3 (1994) 1043-1048
16. Rozen P., Knaani J., and Samuel Z. Performance characteristics and comparison of two immunochemical and two guaiac fecal occult blood screening tests for colorectal neoplasia. Dig Dis Sci 42 (1997) 2064-2071
17. Greenberg P.D., Bertario L., Gnauck R., et al. A prospective multicenter evaluation of new fecal occult blood tests in patients undergoing colonoscopy. Am J Gastroenterol 95 (2000) 1331-1338
18. Rozen P., Knaani J., and Samuel Z. Comparative screening with a sensitive guaiac and specific immunochemical occult blood test in an endoscopic study. Cancer 89 (2000) 46-52
19. Ko C.W., Dominitz J.A., and Nguyen T.D. Fecal occult blood testing in a general medical clinic: comparison between guaiac-based and immunochemical-based tests. Am J Med 115 (2003) 111-114
20. Petrelli N., Michalek A.M., Freedman A., et al. Immunochemical versus guaiac occult blood stool tests: results of a community-based screening program. Surg Oncol 3 (1994) 27-36
21. Robinson M.H., Marks C.G., Farrands P.A., et al. Population screening for colorectal cancer: comparison between guaiac and immunological faecal occult blood tests. Br J Surg 81 (1994) 448-451
22. Castiglione G., Zappa M., Grazzini G., et al. Immunochemical vs guaiac faecal occult blood tests in a population-based screening programme for colorectal cancer. Br J Cancer 74 (1996) 141-144
23. Guittet L., Bouvier V., Mariotte N., et al. Comparison of a guaiac based and an immunochemical faecal occult blood test in screening for colorectal cancer in a general average risk population. Gut 56 (2007) 210-214
24. Allison J.E. Review article: faecal occult blood testing for colorectal cancer. Aliment Pharmacol Ther 12 (1998) 1-10
25. Castiglione G., Grazzini G., Miccinesi G., et al. Basic variables at different positivity thresholds of a quantitative immunochemical test for faecal occult blood. J Med Screen 9 (2002) 99-103
26. Sohn D.K., Jeong S.Y., Choi H.S., et al. Single immunochemical fecal occult blood test for detection of colorectal neoplasia. Cancer Research and Treatment 37 (2005) 20-23
27. Grazzini G., Castiglione G., Ciabattoni C., et al. Colorectal cancer screening programme by faecal occult blood test in Tuscany: first round results. Eur J Cancer Prev 13 (2004) 19-26
28. Rubeca T., Rapi S., Confortini M., et al. Evaluation of diagnostic accuracy of screening by fecal occult blood testing (FOBT). Comparison of FOB Gold and OC sensor assays in a consecutive prospective screening series. Int J Biol Markers 21 (2006) 157-161
29. Chiang C.H., Jeng J.E., Wang W.M., et al. A comparative study of three fecal occult blood tests in upper gastrointestinal bleeding. Kaohsiung J Med Sci 22 (2006) 223-228
30. Fenocchi E., Martinez L., Tolve J., et al. Screening for colorectal cancer in Uruguay with an immunochemical faecal occult blood test. Eur J Cancer Prev 15 (2006) 384-390
31. Winawer S.J., Zauber A.G., Fletcher R.H., et al. Guidelines for colonoscopy surveillance after polypectomy: a consensus update by the US Multi-Society Task Force on Colorectal Cancer and the American Cancer Society. Gastroenterology 130 (2006) 1872-1885
32. Brecht J.G., and Robra B.P. A graphic method of estimating the specificity of screening programmes from incomplete follow-up data. Methods Inf Med 26 (1987) 53-58
33. Lieberman D. Colorectal cancer screening in primary care. Gastroenterology 132 (2007) 2591-2594
34. Lieberman D.A., Weiss D.G., Bond J.H., et al. Use of colonoscopy to screen asymptomatic adults for colorectal cancer. Veterans Affairs Cooperative Study Group 380. N Engl J Med 343 (2000) 162-168
35. Segnan N., Senore C., Andreoni B., et al. Comparing attendance and detection rate of colonoscopy with sigmoidoscopy and FIT for colorectal cancer screening. Gastroenterology 132 (2007) 2304-2312
36. Betes M., Munoz-Navas M.A., Duque J.M., et al. Use of colonoscopy as a primary screening test for colorectal cancer in average risk people. Am J Gastroenterol 98 (2003) 2648-2654
37. Regula J., Rupinski M., Kraszewska E., et al. Colonoscopy in colorectal-cancer screening for detection of advanced neoplasia. N Engl J Med 355 (2006) 1863-1872
38. Terhaar sive Droste J.S., Craanen M.E., Kolkman J.J., et al. Dutch endoscopic capacity in the era of colorectal cancer screening. Neth J Med 64 (2006) 371-373
39. Pignone M., Campbell M.K., Carr C., et al. Meta-analysis of dietary restriction during fecal occult blood testing. Eff Clin Pract 4 (2001) 150-156
40. Norfleet R.G. Effect of diet on fecal occult blood testing in patients with colorectal polyps. Dig Dis Sci 31 (1986) 498-501
41. Sedjo R.L., Byers T., Levin T.R., et al. Change in body size and the risk of colorectal adenomas. Cancer Epidemiol Biomarkers Prev 16 (2007) 526-531
42. Manus B., Adang R.P., Ambergen A.W., Bret al. The risk factor profile of recto-sigmoid adenomas: a prospective screening study of 665 patients in a clinical rehabilitation centre. Eur J Cancer Prev 6 (1997) 38-43
43. Ahmed F.E. Effect of diet, life style, and other environmental/chemopreventive factors on colorectal cancer development, and assessment of the risks. J Environ Sci Health C Environ Carcinog Ecotoxicol Rev 22 (2004) 91-147
44. Kronborg O., Fenger C., Olsen J., et al. Repeated screening for colorectal cancer with fecal occult blood test. A prospective randomized study at Funen, Denmark. Scand J Gastroenterol 24 (1989) 599-606
45. Winawer S.J., Zauber A.G., O'Brien M.J., et al. Randomized comparison of surveillance intervals after colonoscopic removal of newly diagnosed adenomatous polyps. The National Polyp Study Workgroup. N Engl J Med 328 (1993) 901-906
46. Loeve F., Boer R., Zauber A.G., et al. National Polyp Study data: evidence for regression of adenomas. Int J Cancer 111 (2004) 633-639